These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37980185)

  • 1. Intellectual property and funding: fueling Chinese synbio.
    Liao L; Lou Y; Tang X; Deng Z; Gao J
    Trends Biotechnol; 2024 Mar; 42(3):258-260. PubMed ID: 37980185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications.
    van Zimmeren E; Rutz B; Minssen T
    Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosafety and biosecurity: treading China's synbio tightrope.
    Lou Y; Tang X; Liao L; Deng Z; Gao J
    Trends Biotechnol; 2024 Apr; 42(4):389-392. PubMed ID: 37957090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethics and engagement: steering China's synbio future.
    Tang X; Liao L; Lou Y; Deng Z; Gao J
    Trends Biotechnol; 2024 May; 42(5):513-516. PubMed ID: 37968158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property protection for traditional medical knowledge in China's context: a round peg in a square hole?
    Xia N
    Med Law Rev; 2023 Aug; 31(3):358-390. PubMed ID: 37018625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic biology and intellectual property rights: six recommendations.
    Minssen T; Rutz B; van Zimmeren E
    Biotechnol J; 2015 Feb; 10(2):236-41. PubMed ID: 25676051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual property. China's innovation landscape.
    Huang KG
    Science; 2010 Aug; 329(5992):632-3. PubMed ID: 20689003
    [No Abstract]   [Full Text] [Related]  

  • 8. Governing synthetic biology for global health through responsible research and innovation.
    Douglas CM; Stemerding D
    Syst Synth Biol; 2013 Sep; 7(3):139-50. PubMed ID: 24432151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsibility and intellectual property in synthetic biology: A proposal for using Responsible Research and Innovation as a basic framework for intellectual property decisions in synthetic biology.
    König H; Dorado-Morales P; Porcar M
    EMBO Rep; 2015 Sep; 16(9):1055-9. PubMed ID: 26268525
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbon emission reduction effects of intellectual property institution construction in China.
    Qian L; Zhou Y; Sun Y; Zhou Q; Zhang M
    Environ Sci Pollut Res Int; 2023 Jun; 30(27):70569-70591. PubMed ID: 37156945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and management of the biosecurity for synthetic biology.
    Zeng X; Jiang H; Yang G; Ou Y; Lu S; Jiang J; Lei R; Su L
    Synth Syst Biotechnol; 2022 Jun; 7(2):784-790. PubMed ID: 35387231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of intellectual property rights protection on green innovation: A quasi-natural experiment based on the pilot policy of the Chinese intellectual property court.
    Liu Y; Chen L; Luo H; Liu Y; Wen Y
    Math Biosci Eng; 2024 Jan; 21(2):2587-2607. PubMed ID: 38454697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting justice in stem cell intellectual property.
    Regenberg A; Mathews DJ
    Regen Med; 2011 Nov; 6(6 Suppl):79-84. PubMed ID: 21999266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Di'ao Xinxuekang set a precedent for drugs with China's independent intellectual property rights to enter the European and American markets].
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):827. PubMed ID: 22978113
    [No Abstract]   [Full Text] [Related]  

  • 15. A quantitative risk assessment method for synthetic biology products in the environment.
    Rycroft T; Hamilton K; Haas CN; Linkov I
    Sci Total Environ; 2019 Dec; 696():133940. PubMed ID: 31446290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the evolution driving mechanism of IPM to regional economic development.
    Yang X; Qi Y
    Math Biosci Eng; 2022 Apr; 19(7):6699-6711. PubMed ID: 35730278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current landscape and future directions of synthetic biology in South America.
    Gomez-Hinostroza ES; Gurdo N; Alvan Vargas MVG; Nikel PI; Guazzaroni ME; Guaman LP; Castillo Cornejo DJ; Platero R; Barba-Ostria C
    Front Bioeng Biotechnol; 2023; 11():1069628. PubMed ID: 36845183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic biology: a utilitarian perspective.
    Smith K
    Bioethics; 2013 Oct; 27(8):453-63. PubMed ID: 24010857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. China's science, technology, engineering, and mathematics (STEM) research environment: A snapshot.
    Han X; Appelbaum RP
    PLoS One; 2018; 13(4):e0195347. PubMed ID: 29614123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.